Hepatocyte transplantation for glycogen storage disease type Ib

Cell Transplantation

Volumn 16, Issue 6, 2007, Pages 629-637

  Lee, Kwang Woong ^a   Lee, Ji Hyun ^b   Sung, Wook Shin ^a   Sung, Joo Kim ^a   Jae, Won Joh ^a   Lee, Doo Hoon ^c   Kim, Jong Won ^a   Park, Hwa Young ^a   Lee, Soo Youn ^a   Hwan, Hyo Lee ^a   Jin, Wan Park ^a   Kim, Shi Yeon ^b   Yoon, Hee Hoon ^c   Jung, Doo Hee ^c   Yon, Ho Choe ^a   Lee, Suk Koo ^a,d  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Dongguk University   (South Korea)

^d Sungkyunkwan University   (South Korea)

Author keywords

Glycogen storage disease; Hepatocyte; Transplantation

Indexed keywords

GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CADAVER; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; CRYOPRESERVATION; ENZYME ACTIVITY; GLYCOGEN STORAGE DISEASE TYPE 1; GLYCOGEN STORAGE DISEASE TYPE 1B; HEPATOCYTE TRANSPLANTATION; HUMAN; LIVER BIOPSY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; ADOLESCENT; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; FOLLOW UP; HISTOCOMPATIBILITY; IMMUNOLOGY; KOREA; LIVER; LIVER CELL; METABOLISM; PATHOLOGY; TRANSPLANTATION; TREATMENT OUTCOME;

ADOLESCENT; CADAVER; FOLLOW-UP STUDIES; GLUCOSE-6-PHOSPHATASE; GLUCOSE-6-PHOSPHATE; GLYCOGEN STORAGE DISEASE TYPE I; HEPATOCYTES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KOREA; LIVER; MALE; QUALITY OF LIFE; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTS; TREATMENT OUTCOME;

EID: 38449106927     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000007783465019     Document Type: Article

References (26)

1. Adachi, M.; Shinkai, M.; Ohhama, Y.; Tachibana, K.; Kuratsuji, T.; Saji, H.; Maruya, E. Improved neutrophil function in a glycogen storage disease type 1b patient after liver transplantation. Eur. J. Pediatr. 163:202-206; 2004.
2. Arion, W. J.; Lange, A. J.; Walls, H. E.; Ballas, L. M. Evidence for the participation of independent translocation for phosphate and glucose 6-phosphate in the microsomal glucose-6-phosphatase system. Interactions of the system with orthophosphate, inorganic pyrophosphate, and carbamyl phosphate. J. Biol. Chem. 255:10396-10406; 1980.
3. Bhattacharya, N.; Heaton, N.; Rela, M.; Walter, J. H.; Lee, P. J. The benefits of liver transplantation in glycogenosis type Ib. J. Inherit. Metab. Dis. 27:539-540; 2004.
4. Chen, Y. T.; Scheinman, J. I. Hyperglycaemia associated with lactic acidaemia in a renal allograft recipient with type I glycogen storage disease. J. Inherit Metab. Dis. 14:80-86; 1991.
5. Chou, J. Y.; Matern, D.; Mansfield, B. C.; Chen, Y. T. Type I glycogen storage diseases: Disorders of the glucose-6-phosphatase complex. Curr. Mol. Med. 2:121-143; 2002.
6. Dhawan, A.; Mitry, R. R.; Hughes, R. D. Hepatocyte transplantation for liver-based metabolic disorders. J. Inherit. Metab. Dis. 29:431-435; 2006.
7. Fisher, R. A.; Strom, S. C. Human hepatocyte transplantation: Worldwide results. Transplantation 82:441-449; 2006.
8. Han, S. H.; Ki, C. S.; Lee, J. E.; Hong, Y. J.; Son, B. K.; Lee, K. H.; Choe, Y. H.; Lee, S. Y.; Kim, J. W. A novel mutation (A148V) in the glucose 6-phosphate translocase (SLC37A4) gene in a Korean patient with glycogen storage disease type 1b. J. Korean Med. Sci. 20:499-501; 2005.
9. Horslen, S. P.; McCowan, T. C.; Goertzen, T. C.; Warkentin, P. I.; Cai, H. B.; Strom, S. C.; Fox, I. J. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 111:1262-1267; 2003.
10. Hughes, R. D.; Mitry, R. R.; Dhawan, A. Hepatocyte transplantation for metabolic liver disease: UK experience. J. R. Soc. Med. 98:341-345; 2005.
11. Krishna Vanaja, D.; Sivakumar, B.; Jesudasan, R. A.; Singh, L.; Janardanasarma, M. K.; Habibullah, C. M. In vivo identification, survival, and functional efficacy of transplanted hepatocytes in acute liver failure mice model by FISH using Y-chromosome probe. Cell Transplant. 7:267-273; 1998.
12. Labrune, P. Glycogen storage disease type I: Indications for liver and/or kidney transplantation. Eur. J. Pediatr. 161(Suppl. 1):S53-55; 2002.
13. Lachaux, A.; Boillot, O.; Stamm, D.; Canterino, I.; Regnier, F.; Regragui, K.; Floret, D.; Hermier, M. Orthotopic liver transplantation for glycogen storage disease type Ib - treatment with recombinant human granulocyte colony-stimulating factor. Transplant. Proc. 26:265; 1994.
14. Lee, P. J. Glycogen storage disease type I: pathophysiology of liver adenomas. Eur. J. Pediatr. 161(Suppl. 1):S46-49; 2002.
15. Liu, P. P.; de Villa, V. H.; Chen, Y. S.; Wang, C. C.; Wang, S. H.; Chiang, Y. C.; Jawan, B.; Cheung, H. K.; Cheng, Y. F.; Huang, T. L.; Eng, H. L.; Chuang, F. R.; Chen, C. L. Outcome of living donor liver transplantation for glycogen storage disease. Transplant. Proc. 35:366-368; 2003.
16. Martinez-Olmos, M. A.; Lopez-Sanroman, A.; Martin-Vaquero, P.; Molina-Perez, E.; Barcena, R.; Vicente, E.; Candela, A.; Pallardo-Sanchez, L. F. Liver transplantation for type Ib glycogenosis with reversal of cyclic neutropenia. Clin. Nutr. 20:375-377; 2001.
17. Mas, V. R.; Maluf, D. G.; Thompson, M.; Ferreira-Gonzalez, A.; Fisher, R. A. Engraftment measurement in human liver tissue after liver cell transplantation by short tandem repeats analysis. Cell Transplant. 13:231-236; 2004.
18. Mundy, H. R.; Hindmarsh, P. C.; Matthews, D. R.; Leonard, J. V.; Lee, P. J. The regulation of growth in glycogen storage disease type 1. Clin. Endocrinol. (Oxf.) 58:332-339; 2003.
19. Muraca, M.; Gerunda, G.; Neri, D.; Vilei, M. T.; Granato, A.; Feltracco, P.; Meroni, M.; Giron, G.; Burlina, A. B. Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 359:317-318; 2002.
20. Pagano, G.; Cavallo-Perin, P.; Cassader, M.; Bruno, A.; Ozzello, A.; Masciola, P.; Dall'omo, A. M.; Imbimbo, B. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J. Clin. Invest. 72:1814-1820; 1983.
21. Seglen, P. O. Preparation of isolated rat liver cells. Methods Cell Biol. 13:29-83; 1976.
22. Shapiro, A. M.; Lakey, J. R.; Ryan, E. A.; Korbutt, G. S.; Toth, E.; Warnock, G. L.; Kneteman, N. M.; Rajotte, R. V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343:230-238; 2000.
23. Sokal, E. M.; Smets, F.; Bourgois, A.; Van Maldergem, L.; Buts, J. P.; Reding, R.; Bernard Otte, J.; Evrard, V.; Latinne, D.; Vincent, M. F.; Moser, A.; Soriano, H. E. Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: Technique, safety, and metabolic follow-up. Transplantation 76:735-738; 2003.
24. Strom, S. C.; Chowdhury, J. R.; Fox, I. J. Hepatocyte transplantation for the treatment of human disease. Semin. Liver Dis. 19:39-48; 1999.
25. Vidhun, J. R.; Sarwal, M. M. Corticosteroid avoidance in pediatric renal transplantation. Pediatr. Nephrol. 20:418-426; 2005.
26. Wang, L. J.; Chen, Y. M.; George, D.; Smets, F.; Sokal, E. M.; Bremer, E. G.; Soriano, H. E. Engraftment assessment in human and mouse liver tissue after sex-mismatched liver cell transplantation by real-time quantitative PCR for Y chromosome sequences. Liver Transpl. 8:822-828; 2002.